GATTA, ANDREA
GATTA, ANDREA
DIPARTIMENTO DI MEDICINA E INNOVAZIONE TECNOLOGICA
An oncolytic HSV-1 vector induces a therapeutic adaptive immune response against glioblastoma
2024-01-01 Reale, Alberto; Gatta, Andrea; Shaik, Amruth Kaleem Basha; Shallak, Mariam; Chiaravalli, Anna Maria; Cerati, Michele; Zaccaria, Martina; La Rosa, Stefano; Calistri, Arianna; Accolla, Roberto Sergio; Forlani, Greta
Intracranic injection of CIITA-driven MHC-II positive glioblastoma cells induces an effective anti-tumor immune response in vivo: implication for new therapeutic strategies against the glioblastoma
2022-01-01 Gatta, A; Celesti, F; Chiaravalli, Am; Cerati, M; Shallak, M; Tedeschi, A; Sessa, F; Accolla, Rs; Forlani, G
Novel anti-glioblastoma therapeutic vaccines based on optimal stimulation of tumor specific CD4+ T helper cells
2024-03-26 Gatta, Andrea
Novel vaccination strategies based on optimal stimulation of CD4+ T helper cells for the treatment of oral squamous cell carcinoma
2024-01-01 Azzi, L.; Celesti, F.; Chiaravalli, A. M.; Shaik, A. K. B.; Shallak, M.; Gatta, A.; Battaglia, P.; La Rosa, S.; Tagliabue, A.; Accolla, R. S.; Forlani, G.
Protective anti-tumor vaccination against glioblastoma expressing the MHC class II transactivator CIITA
2023-01-01 Celesti, F.; Gatta, A.; Shallak, M.; Chiaravalli, A. M.; Cerati, M.; Sessa, F.; Accolla, R. S.; Forlani, G.
The NLR member CIITA: Master controller of adaptive and intrinsic immunity and unexpected tool in cancer immunotherapy
2023-01-01 Forlani, G.; Shallak, M.; Gatta, A.; Shaik, A. K. B.; Accolla, R. S.
Tumor recognition and acquisition of protecting adaptive anti-tumor immune response in vivo against CIITA-driven MHC class II expressing Oral Squamous Cell Carcinoma Cells
2022-01-01 Celesti, F; Azzi, L; Shallak, M; Gatta, A; Accolla, Rs; Forlani, G